Literature DB >> 16510246

Chronic morphine treatment increases the expression of the neural cell adhesion molecule in the dorsal horn of the mouse spinal cord.

Masami Suzuki1, Minoru Narita, Michiko Narita, Keiichi Niikura, Tsutomu Suzuki.   

Abstract

It is well known that prolonged exposure to morphine results in tolerance to morphine-induced antinociception. In the present study, we found that mice that were tolerant to morphine-induced antinociception exhibited an increase in immunoreactivity for the neural cell adhesion molecule in the dorsal horn of the spinal cord, which was highly overlapped with immunoreactivity for the increased metabotropic glutamate receptor 5 induced by morphine. These findings support the idea that repeated stimulation of mu-opioid receptors increases the expression of neural cell adhesion molecule and metabotropic glutamate receptor 5. This phenomenon leads to the enhanced excitatory synaptic transmission in the dorsal horn of the spinal cord, and in turn suppresses the morphine-induced antinociception.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510246     DOI: 10.1016/j.neulet.2006.01.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Removal of polysialylated neural cell adhesion molecule increases morphine analgesia and interferes with tolerance in mice.

Authors:  Abderrahman El Maarouf; Yuri Kolesnikov; Gavril Pasternak; Urs Rutishauser
Journal:  Brain Res       Date:  2011-06-14       Impact factor: 3.252

3.  Emotional Impairment and Persistent Upregulation of mGlu5 Receptor following Morphine Abstinence: Implications of an mGlu5-MOPr Interaction.

Authors:  Panos Zanos; Polymnia Georgiou; Loreto Rojo Gonzalez; Susanna Hourani; Ying Chen; Ian Kitchen; Brigitte L Kieffer; Raphaelle Winsky-Sommerer; Alexis Bailey
Journal:  Int J Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.